Clinical trials
Recruiting Obesity trials in Czechia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 7 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 23 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 5 |
| Amgen | 2 |
| Ascletis Pharma (China) Co., Limited | 2 |
| Hoffmann-La Roche | 2 |
| Novo Nordisk A/S | 2 |
| AstraZeneca | 1 |
| Boston Scientific Corporation | 1 |
| Charles University, Czech Republic | 1 |
| ENDOPLY | 1 |
| General University Hospital, Prague | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 23 |
| Overweight | 11 |
| Diabetes Mellitus, Type 2 | 6 |
| Heart Failure | 2 |
| Osteoarthritis | 2 |
| Atherosclerosis | 1 |
| Colitis, Ulcerative | 1 |
| Crohn Disease | 1 |
| Fatty Liver | 1 |
| Hypertension | 1 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.